Skip to main content

SiriusPoint Ltd. (SPNT) Stock Analysis

Range Bound setup

HoldVALUE-TRAP 1/5Moderate Confidence

Financial Services · Insurance - Reinsurance

Earnings in 7 days (2026-05-07). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Hold if already holding. Not a fresh buy at $23.37, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (2.4% away).

SiriusPoint is a global specialty insurance and reinsurance underwriter headquartered in Bermuda with offices in 10 countries. The company writes property, casualty, and accident and health lines through Insurance and Services and Reinsurance segments, with $2.3B in shareholders... Read more

$23.37+0.4% A.UpsideScore 5.7/10#4 of 5 Insurance - Reinsurance
Stop $22.27Target $23.49(resistance)A.R:R -0.5:1
Analyst target$26.33+12.7%3 analysts
$23.49our TP
$23.37price
$26.33mean
$31

Hold if already holding. Not a fresh buy at $23.37, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (2.4% away). Chart setup: RSI 59 mid-range, Bollinger mid-band. Mixed signals. Hold existing position. Score 5.7/10, moderate confidence.

Passes 4/7 gates (clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and earnings proximity 7d<=7d. Suitability: aggressive.

Thesis

Rewards
Strong earnings beat streak (4/4)
Attractive valuation
Strong growth profile
Risks
Analyst target reached - limited upside remaining
Near 52-week high (2.4% away)
Earnings in 7 days (event risk)

Key Metrics

P/E (TTM)6.4
P/E (Fwd)8.4
Mkt Cap$2.7B
EV/EBITDA6.4
Profit Mgn15.4%
ROE20.9%
Rev Growth19.4%
Beta0.65
DividendNone
Rating analysts9

Quality Signals

Piotroski F5/9

Options Flow

IV74%elevated

Material Events(8-K, last 90d)

  • 2026-03-30Item 5.02LOW
    Sabra R. Purtill appointed to SiriusPoint Ltd. Board of Directors effective March 25, 2026 as independent director. Named to Audit Committee and Risk and Capital Management Committee. No reason cited; routine board appointment.
    SEC filing →
  • 2026-03-23Item 5.02MEDIUM
    Settlement Agreement finalized with Rob Gibbs, President and CEO of SiriusPoint International, departing April 30, 2026 following business restructuring. Severance of 401,700 GBP. No successor named for the specific role.
    SEC filing →
  • 2026-03-16Item 5.02MEDIUM
    Rob Gibbs, President and CEO of SiriusPoint International subsidiary, to depart following Company restructuring into four global business areas announced March 16, 2026. Separation date and settlement not yet finalized. No successor named.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

1 floor-breaker

Momentum below the gate floor. Component breakdown shows what dragged the score down.static

Volume
0.0
Obv
1.0
Macd
3.2
Rsi
5.5
Ma Position
9.0
Volume distribution (falling OBV)Above 200-day MA
GatesMomentum 3.7<4.5A.R:R -0.5=NEGATIVEEARNINGS PROXIMITY 7d<=7dInsider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTSEMI CYCLE PEAK CLEARRange BoundSuitability: Aggressive
RSI
59 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $21.20Resistance $23.97

Price Targets

$22
$23
A.Upside+0.5%
A.R:R-0.5:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeCautious

Risk Alerts

! Target reached (-4.3% upside)
! Momentum score 3.7/10 — below 4.5 minimum
! Negative risk/reward — downside exceeds upside

Earnings

B
B
B
B
4/4 beats
Next Earnings2026-05-07 (7d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is SPNT stock a buy right now?

Hold if already holding. Not a fresh buy at $23.37, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (2.4% away). Chart setup: RSI 59 mid-range, Bollinger mid-band. Mixed signals. Hold existing position. Target $23.49 (+0.5%), stop $22.27 (−4.9%), A.R:R -0.5:1. Score 5.7/10, moderate confidence.

What is the SPNT stock price target?

Take-profit target: $23.49 (+0.4% upside). Target $23.49 (+0.5%), stop $22.27 (−4.9%), A.R:R -0.5:1. Stop-loss: $22.27.

What are the risks of investing in SPNT?

Analyst target reached - limited upside remaining; Near 52-week high (2.4% away); Earnings in 7 days (event risk).

Is SPNT overvalued or undervalued?

SiriusPoint Ltd. trades at a P/E of 6.4 (forward 8.4). TrendMatrix value score: 7.7/10. Verdict: Hold.

What do analysts say about SPNT?

9 analysts cover SPNT with a consensus score of 4.0/5. Average price target: $26.

What does SiriusPoint Ltd. do?SiriusPoint is a global specialty insurance and reinsurance underwriter headquartered in Bermuda with offices in 10...

SiriusPoint is a global specialty insurance and reinsurance underwriter headquartered in Bermuda with offices in 10 countries. The company writes property, casualty, and accident and health lines through Insurance and Services and Reinsurance segments, with $2.3B in shareholders equity at December 31, 2025.

Related stocks: HG (Hamilton Insurance Group, Ltd.) · RNR (RenaissanceRe Holdings Ltd.) · RGA (Reinsurance Group of America, I) · EG (Everest Group, Ltd.)